Released Presentations
PLENARY SESSIONS

FIRST PLENARY SESSION: HEALTH TECHNOLOGY ASSESSMENT AND HEALTH POLICY: RECENT DEVELOPMENTS ACROSS ASIA

Presentation
Syed Aljunid, Professor, Health Economics and Public Health Medicine & Head, International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia
Presentation
Takashi Fukuda, Director, Department of Health and Welfare Services, National Institute of Public Health, Saitama, Japan
Presentation
Tae-jin Lee, Professor, Health Economics, School of Public Health, Seoul National University and President, Korea Association of Health Economics and Policy, Seoul, South Korea

 

SECOND PLENARY SESSION: HARNESSING THE POWER OF BIG DATA TO MAKE BETTER HEALTH CARE DECISIONS IN THE ASIA-PACIFIC REGION

Presentation
Louisa Jorm, Professor & Director, Centre for Big Data Research in Health, University of New South Wales (UNSW), Sydney, Australia
Presentation
Christopher Chute, Bloomberg Distinguished Professor of Health Informatics, Professor of Medicine, Public Health, and Nursing, and Chief Health Research Information Officer, Johns Hopkins Medicine, Johns Hopkins University, Baltimore, MD, USA
Presentation
Trish Williams, Professor & Chair of Digital Health Technologies, Finders University, Adelaide, Australia

 

THIRD PLENARY SESSION: UNIVERSAL HEALTH COVERAGE - THE AFFORDABLE DREAM IN ASEAN: EXPERIENCES AND LESSONS LEARNED

Presentation
Ahmad Fuad Afdhal, Director, Center for Socio-Economic Studies in Pharmacy, Jakarta, Indonesia
Presentation
Netnapis Suchonwanich, Former Deputy Secretary General, National Health Security Office (NHSO), Bangkok, Thailand
Presentation
Kun Zhao, Professor & Director, Division of Health Policy Evaluation and Technology Assessment, China National Health Development Research Center, National Health and Family Planning Commission (NHFPC), Beijing, China
Presentation
Syed Aljunid, Professor, Health Economics and Public Health Medicine & Head, International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia
Presentation
Graham Harrison, World Health Organization Representative to Malaysia, Brunei Darussalam and Singapore, World Health Organization (WHO), Kuala Lumpur, Malaysia

 

ISSUE PANEL PRESENTATIONS

IP2 : GROWING DEMANDS FOR HTA IN ASIA: HOW CAN PUBLIC-PRIVATE-ACADEMIC PARTNERSHIPS BE STRENGTHENED?

Presentation
Isao Kamae, Professor, Hepatology Research Institute, People'’s Hospital, Peking University, Beijing, China
Jörg Mahlich, Health Economics, Janssen Pharmaceuticals KK, Tokyo, Japan
Akio Onishi, Professor, Graduate School of Public Policy, Tokyo, Japan
Allen Yu-Hung Lai, Principal of Health Economics & Outcomes Research, IMS Health, Singapore, Singapore

 

IP3 : JOINT HTA: THE NEXT STEP FOR THE ASEAN ECONOMIC COMMUNITY?

Presentation
Gengshi Chen, Senior Analyst, Costello Medical Singapore Pte Ltd, Singapore, Singapore
Surachat Ngorsuraches, Associate Professor, Department of Pharmacy Practice, College of Pharmacy, South Dakota State University, Brookings, SD, USA
W. Ken Redekop, Associate Professor, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands

 

IP4 : RISKY BUSINESS: DECISION MAKING IN HEALTH CARE WITH ECONOMIC MODELLING UNCERTAINTY

Presentation
Paul Scuffham, Professor of Health Economics, Population and Social Health Research, Griffith University, Gold Coast, Australia
Presentation
Rosalie Viney, Professor, Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, Australia

 

IP5 : ESTIMATING COUNTRY-SPECIFIC EQ-5D-5L VALUE SETS USING A HYBRID REGRESSION MODEL: IS IT A GOOD IDEA FOR ASIA?

Presentation
Mark Oppe, Senior Scientist, Executive Office, EuroQol Research Foundation, Rotterdam, The Netherlands
Kim Rand-Hendriksen, Post-Doctoral Fellow, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway
Juan Manuel Ramos-Goñi, Research Scientist, The EuroQol Research Foundation, Rotterdam, The Netherlands
Nan Luo, Associate Professor, National University of Singapore, Singapore, Singapore

 

IP6 : HOW DO CULTURE, VALUES, AND INSTITUTIONAL CONTEXT SHAPE THE METHODS AND USE OF ECONOMIC EVALUATION?

Presentation
Michael Drummond, Professor of Health Economics, Centre for Health Economics, University of York, Heslington, York, UK
Presentation
Yen-Huei (Tony) Tarn, Associate Professor, School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan
Presentation
Paul Scuffham, Professor of Health Economics, Population and Social Health Research, Griffith University, Gold Coast, Australia

 

IP9 : PREDICTING FUTURE EVIDENCE: RISK-SHARING AGREEMENTS, MANAGED ENTRY SCHEMES, OR SOMETHING ELSE?

Presentation
Rosalie Viney, Professor, Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, Australia

 

IP10 : CLINICAL TRIALS FOR REGULATORY AND REIMBURSEMENT NEEDS: DOES ONE SHOE FIT ALL?

Presentation
Alissa Brown, Head of Market Access, Sanofi Australia, Macquarie Park, Australia

 

IP11 : HOW CAN RISK-SHARING AGREEMENTS IN KOREA BE IMPROVED?

Presentation
David Grainger, Director, Global Public Policy, Eli Lilly and Company, Sydney, Australia
Presentation
Kevin Haninger, Deputy Vice President, International Health Policy, PhRMA, Washington, DC, USA
Presentation
Nam-Sun Choi, Deputy Manager, Department of Insurance Benefits, National Health Insurance Service (NHIS), Wonju, South Korea
Presentation
Hye-Lin Kim, Assistant Professor, College of Pharmacy, Sahmyook University, Seoul, South Korea

 

IP12 : HOW CAN WE EMPOWER THE PATIENT VOICE IN HEALTH CARE DECISION MAKING AT THE POLICY LEVEL?

Presentation
Eui-Kyung Lee, Professor, Pharmaceutical Policy & Outcomes Research, School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
Richard Vines, Chairman, Rare Cancers Australia, Bowral, Australia
Joerg Klug, Director, Market Access, Janssen Asia Pacific, Kowloon, Hong Kong
Chih-Liang Yaung, President, TAPO (Taiwan Alliance of Patients Organizations), and former Minister of Health, Republic of China, Taiwan

 

IP15 : SHOULD PRODUCTIVITY LOSSES DUE TO ILLNESS BE CONSIDERED IN HEALTH ECONOMIC EVALUATIONS?

Presentation
Hwee Lin Wee, Assistant Professor, Pharmacy, National University of Singapore, Singapore, Singapore
W. Ken Redekop, Associate Professor, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
Craig Brooks-Rooney, Head, Asia-Pacific, Costello Medical Singapore Pte Ltd., Singapore, Singapore
Dominique Milea, Director, Health Economics & Epidemiology Asia, Lundbeck Singapore Pte. Ltd., Singapore, Singapore

 

WORKSHOP PRESENTATIONS

W1 : APPLYING HEALTH TECHNOLOGY ASSESSMENT TO PRECISION MEDICINE: EVALUATING NOVEL DIAGNOSTIC TESTS

Presentation
Hwee Lin Wee, Assistant Professor, Pharmacy, National University of Singapore, Singapore, Singapore
W. Ken Redekop, Associate Professor, Institute of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
Joanne Yoong, Senior Economist, University of Southern California and Associate Professor, National University of Singapore (NSU), Singapore, Singapore
Presentation
W. Ken Redekop, Associate Professor, Institute of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands

 

W2 : EVOLVING METHODS FOR STAGING PROSPECTIVE REAL-WORLD EVIDENCE STUDIES IN MATURE AND EMERGING MARKETS

Presentation
Jianwei Xuan, Advisory Professor, School of Public Health, Fudan University, Shanghai, China
David Thompson, Senior Vice President, Real World Evidence Consulting, inVentivHealth, Burlington, MA, USA
Linda Liong, Project Director, Late Stage Operations, APAC, inVentiv Health, Singapore, Singapore

 

W3 : AN INTRODUCTION TO THE CASEMIX DATABASE IN MALAYSIA, INDONESIA, AND PHILIPPINES

Presentation
Soraya Azmi, Managing Director, Azmi Burhani Consulting, Petaling Jaya, Malaysia
Adrian Goh, Health Economist, Azmi Burhani Consulting, Petaling Jaya, Malaysia
Syed Mohamed Aljunid, Professor, Faculty of Public Health/Department of Health Policy and Management, Kuwait University, Kuwait City, Kuwait
Amrizal Muhd Nur, Senior Research Fellow, Universiti Kebangsaan Malaysia, Cheras, Malaysia

 

W4 : COMBINING TWO TYPES OF VALUATION DATA TO ESTIMATE HEALTH STATE UTILITIES: THE HYBRID REGRESSION MODEL

Presentation
Nan Luo, Assistant Professor, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
Mark Oppe, Senior Scientist, Executive Office, EuroQol Research Foundation, Rotterdam, The Netherlands
Kim Rand-Hendriksen, Post-Doctoral Fellow, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway
Juan Manuel Ramos-Goñi, Research Scientist, The EuroQol Research Foundation, Rotterdam, The Netherlands

 

W6 : ADAPTING PHARMACOECONOMIC DATA OF ANALYSES FROM OVERSEAS FOR USE IN DECISIONS IN MIDDLE INCOME COUNTRIES

Presentation
Michael Drummond, Professor of Health Economics, Centre for Health Economics, University of York, Heslington, York, UK
Presentation
Bong-Min Yang, Professor, School of Public Health and Executive Director, Institute of Health and Environment, Seoul National University, Seoul, South Korea
Presentation
Jasmine Pwu, Senior Investigator, Health Data Research Centre, National Taiwan University, Taipei, Taiwan
Presentation
Nathorn Chaiyakunapruk, Professor of Health Economics, School of Pharmacy, Monash University Malaysia, Selangor, Malaysia

 

W7 : SHARING REAL-WORLD DATA EXPERIENCES OF USING TAIWAN’S NATIONAL HEALTH INSURANCE RESEARCH DATABASE

Presentation
Ming-Hui Tai, Lead Outcomes Research Analyst, Pharmerit International, Bethesda, MD, USA
Presentation
Chung-Hsuen Wu, Assistant Professor, Department of Clinical Pharmacy, Taipei Medical University, Taipei City, Taiwan

 

W8 : APPLIED EARLY ECONOMIC MODELLING FOR COMBINATION THERAPIES IN ONCOLOGY: NOVEL VALUE-BASED PRICING APPROACH

Presentation
Cyrus A. Chowdhury, CEO & Managing Director, CBPartners, New York, NY, USA
Meghan Gallagher, Director, Global Health Economics and Outcomes Research, Oncology, Sanofi, Cambridge, MA, USA
Kateryna Onishchenko, Health Economist, CBPartners, London, UK

 

W12 : INTRODUCING A NOVEL CONCEPT TO OBSERVATIONAL RESEARCH IN THE ASIA-PACIFIC REGION: ENRICHED REAL-WORLD DATA STUDIES

Presentation
Joshua Hiller, Senior Principal, Real-World Evidence Solutions, IMS Health, London, UK
Laura Garcia Alvarez, Engagement Manager, Real-World Evidence Solutions, IMS Health, Barcelona, Spain
Joanne Yoong, Senior Economist, University of Southern California and Associate Professor, National University of Singapore (NUS), Singapore, Singapore
Ong Leong Seng, Chief Architect & Group Director, Architecture & Innovation, Integrated Health Information System, Ministry of Health Holdings, Singapore, Singapore

 

ISPOR FORUMS

F1 : HEALTH TECHNOLOGY ASSESSMENTS IN UNIVERSAL HEALTH COVERAGE

Presentation
Surachat Ngorsuraches, Associate Professor, College of Pharmacy, South Dakota State University, Brookings, South Dakota, USA and Former Associate Professor, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand
Presentation
Kun Zhao, Professor and Director, Division of Health Policy Evaluation and Technology Assessment, China National Health Development Research Center, National Health and Family Planning Commission (NHFPC), Beijing, China
Presentation
Jitendar Sharma, CEO, Andhra Med Tech Zone (AMTZ) and Head, Division of Healthcare Technology & Director, WHO Collaborating Center for Priority Medical Devices, National Health Systems Resource Centre, Ministry of Health & Family Welfare, New Delhi, India
Presentation
Joanne Yoong, Senior Economist, University of Southern California and Associate Professor, National University of Singapore, Singapore, Singapore

 

F2 : INTEGRATING EVIDENCE-BASED AND COST-EFFECTIVE COMPLEMENTARY AND ALTERNATIVE MEDICINE INTO THE HEALTH CARE SYSTEMS IN ASIA

Presentation
Namkwen Kim, Professor, Pusan National University School of Korean Medicine and Director, Monitoring Center for Korean Medicine and Western Collaboration, Pusan National University Korean Medicine, Yangsan, South Korea
Presentation
Hwee Ling Koh, Associate Professor, Department of Pharmacy, National University of Singapore, Singapore, Singapore
Presentation
Ming Hu, Professor & Director, Pharmaceutical Policy & Pharmaceonomics Research Center, West China School of Pharmacy, Sichuan University, Chengdu, China
Presentation
Wendy Wong, Assistant Professor, Hong Kong Institute of Integrative Medicine, Assistant Professor, School of Chinese Medicine and Deputy Chief Chinese Medicine Practitioner, Integrative Medical Centre, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China

 

F3 : BIG DATA IN ASIA-PACIFIC – A VALUABLE RESOURCE FOR BETTER HEALTH CARE DECISIONS: EXPERIENCES AND LESSONS LEARNED IN AUSTRALIA, JAPAN, SINGAPORE, SOUTH KOREA, AND TAIWAN

Presentation
Bruce Crawford, Senior Principal, Real-World Evidence Solutions, Japan & APAC, IMS Japan K.K., Minato-ku, Tokyo, Japan
Presentation
Libby Roughead, Director & Research Professor, Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, SA, Australia
Presentation
SeungJin Bae, Associate Professor, Pharmacoeconomics and Outcomes Research, Ewha Women's University, Seoul, South Korea
Presentation
Chee-Jen Chang, Director, Clinical Informatics and Medical Statistics Research Center and Professor, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Tao Yuan, Taiwan

 

F4 : VALUE IN HEALTH REGIONAL ISSUES: GUIDANCE ON WRITING GOOD SCIENTIFIC MANUSCRIPTS FOR PUBLICATION

Presentation
Bong-Min Yang, Professor, School of Public Health and Executive Director, Institute of Health and Environment, Seoul National University, Seoul, South Korea
Presentation
Kenneth K. C. Lee, Professor, School of Pharmacy, Monash University Malaysia, Subang Jaya, Malaysia
Presentation
Nathorn Chaiyakunapruk, Professor of Health Economics, School of Pharmacy, Monash University Malaysia, Selangor, Malaysia
Presentation
Shu Chuen Li, Professor, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Newcastle, Australia
Presentation
Jianfei (Jeff) Guo, Professor, University of Cincinnati Health Academic Center, Cincinnati, OH, USA

 

F5 : PHARMACOECONOMIC GUIDELINES IN CHINA, INDIA, INDONESIA, MALAYSIA AND THAILAND

Presentation
Mahendra Kumar Rai, Group Leader & SME, HEOR & Real-World Evidence, Market Access & HEOR, Tata Consultancy Services, Mumbai, India
Presentation
Amad Fuad Afdhal, Director, Center for Socio-Economic Studies in Pharmacy, Cirendeu, Indonesia
Presentation
Syed Aljunid, Professor, International Casemix and Clinical Coding Centre, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia
Presentation
Sitaporn Youngkong, Lecturer, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand

 

EDUCATIONAL SYMPOSIA

VALUE OF NEW DIRECT-ACTING ANTIVIRALS TO TREAT HEPATITIS C INFECTION

Presentation
Ataru Igarashi, Associate Professor, Drug Policy & Management, University of Tokyo, Graduate School of Pharmaceutical Sciences, Tokyo, Japan
Presentation
Yen-Huei (Tony) Tarn, Associate Professor, School of Pharmacy, Kaohsiung Medical University, Kaohsiung City, Taiwan
Presentation
Dan Yock Young, Associate Professor, University Medicine Cluster, National University Hospital of Singapore, Singapore, Singapore

 

MANAGING HIGH-COST INNOVATIVE MEDICINES IN ASIA: WHAT ARE THE LATEST TRENDS AND REAL-WORLD PRACTICE?

Presentation
Chee Jen Chang, Professor, Graduate Institute of Clinical Medical Science, Chang Gung University, Tao-Yun, Taiwan
Jianwei Xuan, Director, Health Economic Research Institute, Sun Yat-sen University, Guangzhou, China
Shu Chuen Li, Professor, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Newcastle, Australia
Riad Dirani, VP, GHEOR, TEVA, Frazer, PA, USA

 

THE ROLE OF HTA IN HEALTH CARE DECISION MAKING

Presentation
Jasmine Pwu, Senior Investigator, Health Data Research Centre, National Taiwan University, Taipei, Taiwan
Presentation
Kun Zhao, Director of HTA, Division of Health Policy Evaluation and Technology Assessment, China National Health Development and Research Center, Beijing, China
Presentation
Louis Garrison, Professor, Pharmaceutical Outcomes Research & Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA
Presentation
Yang Xie, Regional HEOR Lead, Asia Pacific and Emerging Markets, Merck Center for Observational and Real world Evidence (CORE), New York, NY, USA

 

PODIUM AND POSTER PRESENTATIONS


For contributed research podium and poster abstracts and released slide or poster presentations for the ISPOR 7th Asia-Pacific Conference, see: the ISPOR Scientific Presentations Database an electronic database of nearly 44,500 research papers presented at ISPOR International Conference, ISPOR European Conference, and ISPOR Asia-Pacific & Latin America Conferences from 1998 to date.

  • ISPOR Scientific Presentations Database
  • Under Meeting select ISPOR 7th Asia-Pacific Conference – Singapore
  • Select Search for all research podium and poster abstracts and available slide or poster presentations from the meeting. Alternatively search by disease/disorder, topic or subtopic.
OPEN MEETINGS
EDUCATIONAL FORUM
STUDENT SHOWCASE
Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.